Target organ damage in untreated hypertensive patients with primary aldosteronism

An increased risk of target organ damage (TOD) has been reported in patients with primary aldosteronism (PA). However, there is relatively little related research on the correlation between the degree of TOD and those with and without PA in newly diagnosed hypertensive patients. The aim of this stud...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical hypertension (Greenwich, Conn.) Vol. 26; no. 7; pp. 789 - 796
Main Authors Li, Shi‐Min, Huang, Jia‐Yi, Zhu, Ching‐Yan, Ng, Ming‐Yen, Lin, Qing‐Shan, Wu, Min, Liu, Ming‐Ya, Wang, Run, Cao, Gao‐Zhen, Chen, Cong, Wu, Mei‐Zhen, Ren, Qing‐Wen, Tse, Hung‐Fat, Yiu, Kai‐Hang
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.07.2024
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text
ISSN1524-6175
1751-7176
1751-7176
DOI10.1111/jch.14794

Cover

Loading…
Abstract An increased risk of target organ damage (TOD) has been reported in patients with primary aldosteronism (PA). However, there is relatively little related research on the correlation between the degree of TOD and those with and without PA in newly diagnosed hypertensive patients. The aim of this study was to assess the association between PA and TOD among patients with newly diagnosed hypertension. Newly diagnosed hypertensive patients were consecutively recruited from January 2015 to June 2020 at the University of Hong Kong‐Shenzhen Hospital. Patients were stratified into those with and without PA. Data for left ventricular mass index (LVMI), carotid intima‐media thickness (CIMT) and plaque, and microalbuminuria were systematically collected. A total of 1044 patients with newly diagnosed hypertension were recruited, 57 (5.5%) of whom were diagnosed with PA. Patients with PA had lower blood pressure, serum lipids, body mass index, and plasma renin activity and a higher incidence of hypokalemia than those without PA. In contrast, the prevalence of left ventricular hypertrophy, increased CIMT, and microalbuminuria was higher in patients with PA than in those without PA. Multivariable regression analysis demonstrated that PA was independently associated with increased LVMI, CIMT and microalbuminuria. Among patients with newly diagnosed hypertension, those with PA had more severe TOD, including a higher LVMI, CIMT and microalbuminuria, than those without PA. These findings emphasize the need for screening TOD in newly diagnosed hypertension due to underlying PA.
AbstractList An increased risk of target organ damage (TOD) has been reported in patients with primary aldosteronism (PA). However, there is relatively little related research on the correlation between the degree of TOD and those with and without PA in newly diagnosed hypertensive patients. The aim of this study was to assess the association between PA and TOD among patients with newly diagnosed hypertension. Newly diagnosed hypertensive patients were consecutively recruited from January 2015 to June 2020 at the University of Hong Kong‐Shenzhen Hospital. Patients were stratified into those with and without PA. Data for left ventricular mass index (LVMI), carotid intima‐media thickness (CIMT) and plaque, and microalbuminuria were systematically collected. A total of 1044 patients with newly diagnosed hypertension were recruited, 57 (5.5%) of whom were diagnosed with PA. Patients with PA had lower blood pressure, serum lipids, body mass index, and plasma renin activity and a higher incidence of hypokalemia than those without PA. In contrast, the prevalence of left ventricular hypertrophy, increased CIMT, and microalbuminuria was higher in patients with PA than in those without PA. Multivariable regression analysis demonstrated that PA was independently associated with increased LVMI, CIMT and microalbuminuria. Among patients with newly diagnosed hypertension, those with PA had more severe TOD, including a higher LVMI, CIMT and microalbuminuria, than those without PA. These findings emphasize the need for screening TOD in newly diagnosed hypertension due to underlying PA.
An increased risk of target organ damage (TOD) has been reported in patients with primary aldosteronism (PA). However, there is relatively little related research on the correlation between the degree of TOD and those with and without PA in newly diagnosed hypertensive patients. The aim of this study was to assess the association between PA and TOD among patients with newly diagnosed hypertension. Newly diagnosed hypertensive patients were consecutively recruited from January 2015 to June 2020 at the University of Hong Kong-Shenzhen Hospital. Patients were stratified into those with and without PA. Data for left ventricular mass index (LVMI), carotid intima-media thickness (CIMT) and plaque, and microalbuminuria were systematically collected. A total of 1044 patients with newly diagnosed hypertension were recruited, 57 (5.5%) of whom were diagnosed with PA. Patients with PA had lower blood pressure, serum lipids, body mass index, and plasma renin activity and a higher incidence of hypokalemia than those without PA. In contrast, the prevalence of left ventricular hypertrophy, increased CIMT, and microalbuminuria was higher in patients with PA than in those without PA. Multivariable regression analysis demonstrated that PA was independently associated with increased LVMI, CIMT and microalbuminuria. Among patients with newly diagnosed hypertension, those with PA had more severe TOD, including a higher LVMI, CIMT and microalbuminuria, than those without PA. These findings emphasize the need for screening TOD in newly diagnosed hypertension due to underlying PA.An increased risk of target organ damage (TOD) has been reported in patients with primary aldosteronism (PA). However, there is relatively little related research on the correlation between the degree of TOD and those with and without PA in newly diagnosed hypertensive patients. The aim of this study was to assess the association between PA and TOD among patients with newly diagnosed hypertension. Newly diagnosed hypertensive patients were consecutively recruited from January 2015 to June 2020 at the University of Hong Kong-Shenzhen Hospital. Patients were stratified into those with and without PA. Data for left ventricular mass index (LVMI), carotid intima-media thickness (CIMT) and plaque, and microalbuminuria were systematically collected. A total of 1044 patients with newly diagnosed hypertension were recruited, 57 (5.5%) of whom were diagnosed with PA. Patients with PA had lower blood pressure, serum lipids, body mass index, and plasma renin activity and a higher incidence of hypokalemia than those without PA. In contrast, the prevalence of left ventricular hypertrophy, increased CIMT, and microalbuminuria was higher in patients with PA than in those without PA. Multivariable regression analysis demonstrated that PA was independently associated with increased LVMI, CIMT and microalbuminuria. Among patients with newly diagnosed hypertension, those with PA had more severe TOD, including a higher LVMI, CIMT and microalbuminuria, than those without PA. These findings emphasize the need for screening TOD in newly diagnosed hypertension due to underlying PA.
Abstract An increased risk of target organ damage (TOD) has been reported in patients with primary aldosteronism (PA). However, there is relatively little related research on the correlation between the degree of TOD and those with and without PA in newly diagnosed hypertensive patients. The aim of this study was to assess the association between PA and TOD among patients with newly diagnosed hypertension. Newly diagnosed hypertensive patients were consecutively recruited from January 2015 to June 2020 at the University of Hong Kong‐Shenzhen Hospital. Patients were stratified into those with and without PA. Data for left ventricular mass index (LVMI), carotid intima‐media thickness (CIMT) and plaque, and microalbuminuria were systematically collected. A total of 1044 patients with newly diagnosed hypertension were recruited, 57 (5.5%) of whom were diagnosed with PA. Patients with PA had lower blood pressure, serum lipids, body mass index, and plasma renin activity and a higher incidence of hypokalemia than those without PA. In contrast, the prevalence of left ventricular hypertrophy, increased CIMT, and microalbuminuria was higher in patients with PA than in those without PA. Multivariable regression analysis demonstrated that PA was independently associated with increased LVMI, CIMT and microalbuminuria. Among patients with newly diagnosed hypertension, those with PA had more severe TOD, including a higher LVMI, CIMT and microalbuminuria, than those without PA. These findings emphasize the need for screening TOD in newly diagnosed hypertension due to underlying PA.
Author Wu, Min
Li, Shi‐Min
Wu, Mei‐Zhen
Chen, Cong
Huang, Jia‐Yi
Lin, Qing‐Shan
Cao, Gao‐Zhen
Liu, Ming‐Ya
Ren, Qing‐Wen
Wang, Run
Yiu, Kai‐Hang
Ng, Ming‐Yen
Tse, Hung‐Fat
Zhu, Ching‐Yan
AuthorAffiliation 2 Division of Cardiology Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong China
1 Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China
3 Division of Radiology Department of Medicine The University of Hong Kong‐Shenzhen Hospital Shenzhen China
AuthorAffiliation_xml – name: 2 Division of Cardiology Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong China
– name: 1 Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China
– name: 3 Division of Radiology Department of Medicine The University of Hong Kong‐Shenzhen Hospital Shenzhen China
Author_xml – sequence: 1
  givenname: Shi‐Min
  surname: Li
  fullname: Li, Shi‐Min
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China
– sequence: 2
  givenname: Jia‐Yi
  orcidid: 0000-0003-1783-8195
  surname: Huang
  fullname: Huang, Jia‐Yi
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China, Division of Cardiology Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong China
– sequence: 3
  givenname: Ching‐Yan
  surname: Zhu
  fullname: Zhu, Ching‐Yan
  organization: Division of Cardiology Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong China
– sequence: 4
  givenname: Ming‐Yen
  surname: Ng
  fullname: Ng, Ming‐Yen
  organization: Division of Radiology Department of Medicine The University of Hong Kong‐Shenzhen Hospital Shenzhen China
– sequence: 5
  givenname: Qing‐Shan
  surname: Lin
  fullname: Lin, Qing‐Shan
  organization: Division of Radiology Department of Medicine The University of Hong Kong‐Shenzhen Hospital Shenzhen China
– sequence: 6
  givenname: Min
  surname: Wu
  fullname: Wu, Min
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China
– sequence: 7
  givenname: Ming‐Ya
  surname: Liu
  fullname: Liu, Ming‐Ya
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China
– sequence: 8
  givenname: Run
  surname: Wang
  fullname: Wang, Run
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China
– sequence: 9
  givenname: Gao‐Zhen
  surname: Cao
  fullname: Cao, Gao‐Zhen
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China
– sequence: 10
  givenname: Cong
  surname: Chen
  fullname: Chen, Cong
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China
– sequence: 11
  givenname: Mei‐Zhen
  surname: Wu
  fullname: Wu, Mei‐Zhen
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China, Division of Cardiology Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong China
– sequence: 12
  givenname: Qing‐Wen
  surname: Ren
  fullname: Ren, Qing‐Wen
  organization: Division of Cardiology Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong China
– sequence: 13
  givenname: Hung‐Fat
  surname: Tse
  fullname: Tse, Hung‐Fat
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China, Division of Cardiology Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong China
– sequence: 14
  givenname: Kai‐Hang
  orcidid: 0000-0003-2145-3108
  surname: Yiu
  fullname: Yiu, Kai‐Hang
  organization: Division of Cardiology Department of Medicine The University of Hong Kong‐ Shenzhen Hospital Shenzhen China, Division of Cardiology Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38715256$$D View this record in MEDLINE/PubMed
BookMark eNptkk1r3DAQhkVJaT7aQ_9AMfTSHpxIsiVZpxJC2gYCpZCexViWd7XY0laSU_LvM8luQxOqi8TMo5d5Z-aYHIQYHCHvGT1leM42dn3KWqXbV-SIKcFqxZQ8wLfgbS0xckiOc95QKppG0zfksOkU5oQ8Ij9vIK1cqWJaQagGmGHlKh-qJZTkoLihWt9tXSouZH_rqi0U70LJ1R9f1tU2-RnSXQXTEHNxKQaf57fk9QhTdu_29wn59fXy5uJ7ff3j29XF-XVtW0VLrYUYR9A9NJT3XPCR80Zr6mQHjLmh1Vow2TMxQDeMqm2p0FQpkBJ_NwqdnJCrne4QYWP2pZgI3jwG0JCBVLydnKEMesap5cBl2_WNZqMVouMWVKcZk6j1Zae1XfrZDRYtJpieiT7PBL82q3hrGOMNbwVFhU97hRR_Ly4XM_ts3TRBcHHJpqHYb_RMGaIfX6CbuKSAvUKqE1RL2nKkPvxb0lMtf0eHwOcdYFPMObnxCWHUPKyFwbUwj2uB7NkL1vqCo4wPbvz0nx_3r1C4sA
CitedBy_id crossref_primary_10_3390_kidneydial5010003
crossref_primary_10_1111_jch_14896
Cites_doi 10.1046/j.1523-1755.2003.00929.x
10.1016/j.kisu.2021.11.006
10.1161/HYPERTENSIONAHA.117.10644
10.1016/j.ijcard.2016.01.200
10.1016/j.jacc.2020.02.052
10.1210/jc.2008-0104
10.3389/fendo.2022.917356
10.1080/00325481.2017.1272398
10.1161/HYPERTENSIONAHA.118.11339
10.1161/01.HYP.0000230444.01215.6a
10.1161/HYPERTENSIONAHA.113.01060
10.1016/j.cca.2011.02.018
10.1161/01.CIR.0000153800.09920.40
10.1161/01.HYP.0000040261.30455.B6
10.1210/jc.2015-4061
10.1097/HJH.0000000000001251
10.1016/j.echo.2005.10.005
10.1210/jc.2018-00617
10.1016/S2213-8587(17)30367-4
10.1097/HJH.0000000000002216
10.1016/S2213-8587(17)30319-4
10.1161/01.CIR.0000151516.84238.37
10.1097/01.hjh.0000239305.01496.ca
10.1097/HJH.0b013e328360ddf6
10.1097/HJH.0b013e328364ca4c
10.1097/00004872-199917070-00016
10.1161/HYPERTENSIONAHA.119.14601
10.1097/HJH.0000000000002170
10.1016/j.atherosclerosis.2011.12.003
10.1097/00004872-200207000-00017
10.1097/MBP.0b013e3282f13f36
10.1097/HJH.0000000000002441
10.3389/fendo.2020.547356
10.1016/j.jcmg.2013.11.014
10.1210/jc.2013-2805
10.1016/j.jacc.2017.01.052
10.1016/0735-1097(94)00316-I
ContentType Journal Article
Copyright 2024 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.
2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 The Authors. published by Wiley Periodicals LLC.
Copyright_xml – notice: 2024 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.
– notice: 2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 The Authors. published by Wiley Periodicals LLC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1111/jch.14794
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Publicly Available Content Database
MEDLINE - Academic
CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate LI et al
EISSN 1751-7176
EndPage 796
ExternalDocumentID oai_doaj_org_article_01ab120c2a2648b391fc5582ca789116
PMC11232450
38715256
10_1111_jch_14794
Genre Journal Article
GeographicLocations Hong Kong
China
GeographicLocations_xml – name: Hong Kong
– name: China
GrantInformation_xml – fundername: HKU-SZH Fund for Shenzhen Key Medical Discipline
  grantid: SZXK2020081
– fundername: Sanming Project of Medicine in Shenzen, China
  grantid: SZSM201911020
– fundername: HKU‐SZH Fund for Shenzhen Key Medical Discipline
  grantid: SZXK2020081
GroupedDBID ---
0R~
10A
123
1OC
24P
29K
31~
36B
4.4
51W
51X
52M
52N
52P
52R
52S
52X
53G
5LA
5VS
7PT
7X7
8-1
8FI
8FJ
8UM
AAHHS
AAWTL
AAYXX
AAZKR
ABUWG
ACCFJ
ACCMX
ACXQS
AEEZP
AENEX
AEQDE
AFBPY
AFKRA
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
BENPR
BFHJK
CAG
CCPQU
CITATION
COF
CS3
D-I
DU5
EBS
EJD
EMOBN
F5P
FYUFA
G-S
GODZA
GROUPED_DOAJ
HF~
HMCUK
HZ~
J0M
LC2
LC3
LH4
LW6
MY~
N9A
O9-
OIG
OK1
OVD
P2P
PHGZM
PHGZT
PIMPY
Q11
QB0
RPM
SUPJJ
TEORI
UKHRP
WIN
XG1
XV2
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c470t-955ffa9ba302b252f223990e68a11ed499516b15da8df744059077a6647037053
IEDL.DBID BENPR
ISSN 1524-6175
1751-7176
IngestDate Wed Aug 27 01:28:56 EDT 2025
Thu Aug 21 18:32:24 EDT 2025
Thu Sep 04 16:35:59 EDT 2025
Sat Jul 26 02:59:53 EDT 2025
Mon Jul 21 05:58:55 EDT 2025
Tue Jul 01 00:35:40 EDT 2025
Thu Apr 24 23:06:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords target organ damage
untreated hypertension
primary aldosteronism
Language English
License 2024 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-955ffa9ba302b252f223990e68a11ed499516b15da8df744059077a6647037053
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1783-8195
0000-0003-2145-3108
OpenAccessLink https://www.proquest.com/docview/3085096042?pq-origsite=%requestingapplication%
PMID 38715256
PQID 3085096042
PQPubID 5070786
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_01ab120c2a2648b391fc5582ca789116
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11232450
proquest_miscellaneous_3052595501
proquest_journals_3085096042
pubmed_primary_38715256
crossref_primary_10_1111_jch_14794
crossref_citationtrail_10_1111_jch_14794
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-07-01
PublicationDateYYYYMMDD 2024-07-01
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-07-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
– name: Hoboken
PublicationTitle The journal of clinical hypertension (Greenwich, Conn.)
PublicationTitleAlternate J Clin Hypertens (Greenwich)
PublicationYear 2024
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References e_1_2_13_24_1
e_1_2_13_27_1
e_1_2_13_26_1
e_1_2_13_21_1
e_1_2_13_20_1
e_1_2_13_23_1
e_1_2_13_22_1
e_1_2_13_9_1
e_1_2_13_8_1
e_1_2_13_7_1
e_1_2_13_6_1
e_1_2_13_17_1
e_1_2_13_18_1
e_1_2_13_39_1
e_1_2_13_19_1
e_1_2_13_13_1
e_1_2_13_36_1
e_1_2_13_14_1
e_1_2_13_35_1
e_1_2_13_15_1
e_1_2_13_38_1
e_1_2_13_16_1
e_1_2_13_37_1
e_1_2_13_32_1
e_1_2_13_10_1
e_1_2_13_31_1
e_1_2_13_11_1
e_1_2_13_34_1
e_1_2_13_12_1
Williams B (e_1_2_13_25_1) 2018; 19
e_1_2_13_33_1
e_1_2_13_30_1
e_1_2_13_5_1
e_1_2_13_4_1
e_1_2_13_3_1
e_1_2_13_2_1
e_1_2_13_29_1
e_1_2_13_28_1
References_xml – ident: e_1_2_13_15_1
  doi: 10.1046/j.1523-1755.2003.00929.x
– ident: e_1_2_13_14_1
  doi: 10.1016/j.kisu.2021.11.006
– ident: e_1_2_13_35_1
  doi: 10.1161/HYPERTENSIONAHA.117.10644
– ident: e_1_2_13_10_1
  doi: 10.1016/j.ijcard.2016.01.200
– ident: e_1_2_13_19_1
  doi: 10.1016/j.jacc.2020.02.052
– ident: e_1_2_13_22_1
  doi: 10.1210/jc.2008-0104
– ident: e_1_2_13_13_1
  doi: 10.3389/fendo.2022.917356
– ident: e_1_2_13_18_1
  doi: 10.1080/00325481.2017.1272398
– ident: e_1_2_13_36_1
  doi: 10.1161/HYPERTENSIONAHA.118.11339
– ident: e_1_2_13_20_1
  doi: 10.1161/01.HYP.0000230444.01215.6a
– ident: e_1_2_13_11_1
  doi: 10.1161/HYPERTENSIONAHA.113.01060
– volume: 19
  start-page: 3S
  issue: 11
  year: 2018
  ident: e_1_2_13_25_1
  article-title: [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]
  publication-title: G Ital Cardiol (Rome)
– ident: e_1_2_13_9_1
  doi: 10.1016/j.cca.2011.02.018
– ident: e_1_2_13_16_1
  doi: 10.1161/01.CIR.0000153800.09920.40
– ident: e_1_2_13_3_1
  doi: 10.1161/01.HYP.0000040261.30455.B6
– ident: e_1_2_13_4_1
  doi: 10.1210/jc.2015-4061
– ident: e_1_2_13_8_1
  doi: 10.1097/HJH.0000000000001251
– ident: e_1_2_13_23_1
  doi: 10.1016/j.echo.2005.10.005
– ident: e_1_2_13_37_1
  doi: 10.1210/jc.2018-00617
– ident: e_1_2_13_5_1
  doi: 10.1016/S2213-8587(17)30367-4
– ident: e_1_2_13_33_1
  doi: 10.1097/HJH.0000000000002216
– ident: e_1_2_13_7_1
  doi: 10.1016/S2213-8587(17)30319-4
– ident: e_1_2_13_12_1
  doi: 10.1161/01.CIR.0000151516.84238.37
– ident: e_1_2_13_26_1
  doi: 10.1097/01.hjh.0000239305.01496.ca
– ident: e_1_2_13_17_1
  doi: 10.1097/HJH.0b013e328360ddf6
– ident: e_1_2_13_21_1
  doi: 10.1097/HJH.0b013e328364ca4c
– ident: e_1_2_13_28_1
  doi: 10.1097/00004872-199917070-00016
– ident: e_1_2_13_38_1
  doi: 10.1161/HYPERTENSIONAHA.119.14601
– ident: e_1_2_13_34_1
  doi: 10.1097/HJH.0000000000002170
– ident: e_1_2_13_32_1
  doi: 10.1016/j.atherosclerosis.2011.12.003
– ident: e_1_2_13_27_1
  doi: 10.1097/00004872-200207000-00017
– ident: e_1_2_13_29_1
  doi: 10.1097/MBP.0b013e3282f13f36
– ident: e_1_2_13_31_1
  doi: 10.1097/HJH.0000000000002441
– ident: e_1_2_13_6_1
  doi: 10.3389/fendo.2020.547356
– ident: e_1_2_13_24_1
  doi: 10.1016/j.jcmg.2013.11.014
– ident: e_1_2_13_39_1
  doi: 10.1210/jc.2013-2805
– ident: e_1_2_13_2_1
  doi: 10.1016/j.jacc.2017.01.052
– ident: e_1_2_13_30_1
  doi: 10.1016/0735-1097(94)00316-I
SSID ssj0053390
Score 2.382027
Snippet An increased risk of target organ damage (TOD) has been reported in patients with primary aldosteronism (PA). However, there is relatively little related...
Abstract An increased risk of target organ damage (TOD) has been reported in patients with primary aldosteronism (PA). However, there is relatively little...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 789
SubjectTerms Adult
Aged
Albuminuria - diagnosis
Albuminuria - epidemiology
Albuminuria - etiology
Blood pressure
Blood Pressure - physiology
Body mass index
Cardiovascular disease
Carotid arteries
Carotid Intima-Media Thickness
Cholesterol
Creatinine
Diabetes
Female
Hong Kong - epidemiology
Humans
Hyperaldosteronism - complications
Hyperaldosteronism - diagnosis
Hyperaldosteronism - epidemiology
Hypertension
Hypertension - complications
Hypertension - epidemiology
Hypertrophy, Left Ventricular - diagnosis
Hypertrophy, Left Ventricular - epidemiology
Hypertrophy, Left Ventricular - etiology
Hypertrophy, Left Ventricular - physiopathology
Hypokalemia - diagnosis
Hypokalemia - epidemiology
Hypokalemia - etiology
Male
Middle Aged
Original
Prevalence
primary aldosteronism
Risk Factors
Statistical analysis
target organ damage
Ultrasonic imaging
untreated hypertension
Veins & arteries
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iQbyIb-uLKB68FJtXmz2quCzCCsIueCtJk7KCVnF3_78zabbsiuDFazNpk8mkmS-ZfEPIlTeMGW9dWjPcurFCpTaXPuXeeVPAgmFCrsPhUz4Yy8cX9bKU6gtjwlp64FZxNxkzlvGsgkq51Fb0WF0ppXllCg0TNZBtw5q3AFPtPxh8mLC7At-SeAlORU6hEMMD5sOQV31lJQqE_b95mT-DJZdWn_422YpuI71tm7tD1nyzSzaG8WB8jzyPQkQ3DUmaqDPv8Jugrw2dNyGS3Ds6AcD5FcPVaWRTnVLchqWfLeMENW8Or3wgW-70fZ-M-w-j-0EasyWklSyyWdpTqq5NzxqRccsVrzleW818rmE4vANko1humXJGuxppARXg4sLkOdQWBajsgKw3H40_IrTSPqu9dJWShXRaaHCaAKepWhbCS2ETcr3QXFlFKnHMaPFWdpCimpRByQm57ERjb34TukP1dwJIeR0egNLKaAjlX4aQkNPF4JVxHk5LgYx8yD_DE3LRFcMMwmMR0_iPOcoowICA1FhCDtux7loiNNqrgpfrFStYaepqSfM6CSzdLDirKjv-j86dkE0O3lQbJ3xK1mdfc38G3tDMngfD_wYqMQXX
  priority: 102
  providerName: Directory of Open Access Journals
Title Target organ damage in untreated hypertensive patients with primary aldosteronism
URI https://www.ncbi.nlm.nih.gov/pubmed/38715256
https://www.proquest.com/docview/3085096042
https://www.proquest.com/docview/3052595501
https://pubmed.ncbi.nlm.nih.gov/PMC11232450
https://doaj.org/article/01ab120c2a2648b391fc5582ca789116
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDLfYTUK8IBgfK2yngHjgpaL5anJPiE2bpkmbAG3SvVVJk-ombb2xu_v_sXO5wqGJ19ZtU9txbMf5GeBTdJy76EPZcUrdeKlLX6tYihiiM7hguNTr8OKyPrtW51M9zQm3RS6r3NjEZKjDvKUc-RdJ2GqEJCK-3v8qqWsU7a7mFho7sIsm2OoR7B6dXH7_ubHF6MukLAt-U9FhOJ2xhVItD6oRJ3z1rRUpAfc_5m3-WzT51yp0-gKeZ_eRfVvL-yU8if0ePL3IG-Sv4MdVquxmqVkTC-4OzQW76dmqTxXlMbAZBp4PuWydZVTVBaN0LLtfI08wdxvo6Aeh5i7uXsP16cnV8VmZuyaUrTLVspxo3XVu4p2shBdadIKOr1axtiiWGDDC0bz2XAdnQ0fwgBrjY-PqGp-WBln2Bkb9vI_7wFobqy6q0GplVLDSovOE8ZrulJFRSV_A5w3nmjZDilNni9tmCC3aWZOYXMDHgTT_zWNER8T-gYCgr9MFZFqTZ1JTcee5qFrUolpZLye8a7W2onXGouWuCzjYCK_J83HR_NGeAj4Mt3Em0faI6-N8RTQaY0GM2HgBb9eyHkYiLemtxpfbLS3YGur2nf5mltC6eXJadfXu_-N6D88E-kvrSuADGC0fVvEQ_Z2lH8OOmZpxVu1xyhr8BljUAbY
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9NmwS8IL4JDDAIJF4iYsdO3AeEGGzq2FoB6qS9BTt21ElbOtZWiH-Kv5E7xykUTbztNXaiy_k-7fPvAF56w7nx1qUNp60bm6vUFtKnwjtvSnQYJvQ6HI2L4ZH8dKyON-BXfxeGyip7mxgMtZvVtEf-JidsNUISEe_Ov6fUNYpOV_sWGp1YHPifPzBlm7_d_4jr-0qIvd3Jh2EauwqktSyzRTpQqmnMwJo8E1Yo0Qi63pn5QiPZ3mEGoHhhuXJGu4bg8xTmj6UpCnw7LzPqEoEmfwvDjAFq0dbO7vjz1972Y-wUdnXwHyVdvlMRyyjUDqHYcsJzX_OAoVHAZdHtv0Waf3m9vVtwM4ar7H0nX7dhw7d34NooHsjfhS-TUEnOQnMo5swZmid20rJlGyrYvWNTTHQvYpk8iyiuc0bbv-y8Q7pg5tTRVRNC6Z2f3YOjK-HnfdhsZ61_CKzWPmu8dLWSpXQ61xisYX6oGlnmXuY2gdc956o6QphTJ43TapXK1NMqMDmBF6up8W8um7RD7F9NIKjt8ACZVkXNrTJuLBdZjVJbSG3zAW9qpbSoTanRUxQJbPeLV0X9n1d_pDWB56th1Fw6jjGtny1pjsLcEzNEnsCDbq1XlOSa9EThx_WaFKyRuj7SnkwDOjgPQbLKHv2frmdwfTgZHVaH--ODx3BDYKzWVSFvw-biYumfYKy1sE-jgDP4dtU69RuGYjn9
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VW6nigngTKGAQSFyixo6deA8IUdpVS-mqoFbqLdixo63UZkt3V4i_xq9jxnEWFlXcek2cyB7P2-NvAF57w7nx1qUNp9SNzVVqC-lT4Z03JRoME3odHo6LvRP56VSdrsGv_i4MlVX2OjEoajetKUe-lRO2GiGJiK0mlkUc7YzeX35PqYMUnbT27TQ6FjnwP39g-DZ7t7-De_1GiNHu8ce9NHYYSGtZZvN0qFTTmKE1eSasUKIRdNUz84XGJXiH0YDiheXKGe0agtJTGEuWpijw67zMqGMEqv_1Eq2iHsD69u746GtvB9CPChkeXK-ki3gq4hqFOiJkYU7Y7ivWMDQNuM7T_bdg8y8LOLoDt6Pryj50vHYX1nx7DzYO4-H8ffhyHKrKWWgUxZy5QFXFzlq2aEM1u3dsgkHvVSyZZxHRdcYoFcwuO9QLZs4dXTshxN7ZxQM4uRF6PoRBO239Y2C19lnjpauVLKXTuUbHDWNF1cgy9zK3CbztKVfVEc6cumqcV8uwpp5UgcgJvFoOjau5btA2kX85gGC3wwMkWhWluMq4sVxkNXJwIbXNh7ypldKiNqVGq1EksNlvXhV1waz6w7kJvFy-RimmoxnT-umCxiiMQzFa5Ak86vZ6OZNck8wo_Lle4YKVqa6-ac8mASmcB4dZZU_-P68XsIGyVH3eHx88hVsC3bauIHkTBvOrhX-GbtfcPo_8zeDbTYvUbxS-Pik
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Target+organ+damage+in+untreated+hypertensive+patients+with+primary+aldosteronism&rft.jtitle=The+journal+of+clinical+hypertension+%28Greenwich%2C+Conn.%29&rft.au=Li%2C+Shi%E2%80%90Min&rft.au=Huang%2C+Jia%E2%80%90Yi&rft.au=Zhu%2C+Ching%E2%80%90Yan&rft.au=Ng%2C+Ming%E2%80%90Yen&rft.date=2024-07-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=1524-6175&rft.eissn=1751-7176&rft.volume=26&rft.issue=7&rft.spage=789&rft.epage=796&rft_id=info:doi/10.1111%2Fjch.14794&rft_id=info%3Apmid%2F38715256&rft.externalDocID=PMC11232450
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-6175&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-6175&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-6175&client=summon